Managers/MPM Bioimpact/Ansbert, Karl Gadicke

Ansbert, Karl Gadicke

Ansbert, Karl Gadicke is trustee at MPM Bioimpact. The firm has 2 funds on file, which have raised $677.8M.

Title
Trustee
Funds on file
2
Raised across them
$677.8M

At the firm

TitleTrustee
Owns25% to 50% of the firm
ControlOne of the people who control the firm
In this position sinceJanuary 2012
Role on the fundsDirector, Executive officer, Promoter
Funds named on4

The firm's funds

MPM BioVentures 2022, L.P. Private equity $351M Jun 2023
Oncology Impact Fund 2, L.P. Private equity $326.8M Nov 2021